ALGS•benzinga•
Aligos Therapeutics Presents Data From One Late-Breaker Oral And 3 Poster Presentations At The American Association For The Study Of Liver Disease's The Liver Meeting 2024; 12-Weeks Of Once Daily ALG-055009 Treatment In MASH Patients Met The Primary Endpo
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 19, 2024 by benzinga